Podcasts about t2d

  • 124PODCASTS
  • 288EPISODES
  • 34mAVG DURATION
  • 5WEEKLY NEW EPISODES
  • Dec 1, 2022LATEST

POPULARITY

20152016201720182019202020212022


Best podcasts about t2d

Latest podcast episodes about t2d

The Discover Strength Podcast
"Resistance Training for Metabolic Health" with Dr. Jurgen Giessing Ph.D.

The Discover Strength Podcast

Play Episode Listen Later Dec 1, 2022 45:16


In this week's episode of the Discover Strength Podcast, I had the pleasure of sitting down with a world-renowned expert on the benefits of resistance training for metabolic health. Dr. Giessing is a professor of Sports Science at the University of Koblenz-Landau. He's also a coauthor on a number of research papers we've discussed on this podcast in the past.Dr. Giessing has worked closely with Dr. James Fisher and Dr. James Steele on a number of different projects. The paper we specifically discuss today is on the effects that resistance training has on metabolic health.For this discussion, we focus specifically on a paper published in 2021, in which Dr. Giessing's group investigated the effects of a resistance training intervention on patients receiving routine care for Type-2 diabetes (T2D). This minimum dose exercise approach was given as an intervention along with a normal standard of care to help patients understand and maximize their own metabolic health.The results of this study, which last over 2 years, and is still having intermediate check-ups are fascinating. It appears that along with dietary interventions and education about T2D, minimum dose resistance training (very similar to what we practice at Discover Strength) was extremely effective in improving overall markers of metabolic health.Dr. Giessing and I discuss important takeaways from this paper, as well as practical implications for those that may already be diabetic, or are on their way to becoming T2D, based on lifestyle and overall metabolic health.I recommend listening and taking notes on this one, as well as sharing it with anyone you may know who is suffering from T2D, or has below-average metabolic health.Check out the paper HERE! Dr. Giessing is also an author and has written one of the best books ever on High Intensity Training. I highly recommend checking it out and sharing it with anyone who you think might be interested in this style of training. Purchase the book HERE!If you or someone you know is interested in trying out a FREE Discover Strength Introductory workout, please send them our way!Send any inquiries HERE to get scheduled for a FREE Introductory Session today to take the first step towards getting your life back. Schedule your FREE Introductory Workout Session in studio or online by following the link HERE.

Healthed Australia
Low carbohydrate diets to manage Type 2 Diabetes

Healthed Australia

Play Episode Listen Later Dec 1, 2022 30:02


How Type 2 Diabetes (T2D) remission sounds impossible, but is achievable and endorsed by Diabetes Australia in their "Type 2 Diabetes Position Statement" October 2021 The compelling and beneficial impact of introducing a low carb dietary intervention to patients with T2D, rather than surgery or prescribing more drugs Finding the Holy Grail for the management of T2D with free lifetime access to the Defeat Diabetes app and program. Get more information and gain CPD points to benefit yourself, your colleagues and especially your patients Host: Dr David Lim | Total Time: 30 mins Guest: Dr Peter Brukner OAM, Sports and Exercise Medicine Physician Register for our fortnightly FREE WEBCASTSEvery second Tuesday | 7:00pm-9:00pm AEDT Click here to register for the next oneSee omnystudio.com/listener for privacy information.

The Primal Pioneer
Type II Diabetes: How to prevent & reverse with diet, light & homeopathy

The Primal Pioneer

Play Episode Listen Later Nov 29, 2022 58:09


During this episode classical homeopath and author of The Sunlight Rx and The Sunlight Diet, Heathar Shepard, talks all about root causes of T2D. Heathar teaches you the connection between light, diet, genetic predisposition and diabetes and how to use sunlight, diet and homeopathy to reverse and prevent this condition.

Let's Talk Health with Mairi
Sugar Awareness Week: Does Sugar Consumption Really Cause Type 2 Diabetes?

Let's Talk Health with Mairi

Play Episode Listen Later Nov 20, 2022 29:34


Hello everyone and welcome back to the podcast! I hope you all have had a wonderful week! This week (14th-20th of November) is  Sugar Awareness Week! To bring this wonderful week to a close, I bring you a podcast about sugar and the common condition, type 2 diabetes, and how they relate. This is a fascinating topic! Listen to this episode now and let's take a deep dive into the literature on sugar and type 2 diabetes. Check out my Instagram (and other health professionals) to learn more about sugar and why we should be careful about how much we consume. Get in touch: Email: gardnermairi12345@gmail.comInstagram: mairihgardnerTiktok: mairigardner57 Blog: aaahealths.com Website: www.mairigardner.com Do you have any questions about what I offer and how I can help you? Book your FREE 15-minute session today @ www.mairigardner.com I would love to chat! Remember to share, like, comment, and follow along for more! 

Medical Industry Feature
CKD in T2D: Exploring Strategies and Tools for Early Risk Assessment

Medical Industry Feature

Play Episode Listen Later Nov 18, 2022


Host: Jennifer Caudle, DO Guest: Joseph Aloi, MD The rate of chronic kidney disease (CKD) in patients with type 2 diabetes (T2D) continues to rise. What can we do to slow this progression of CKD? Dr. Joseph Aloi from the Wake Forest School of Medicine explores this growing epidemic and discusses how a new tool may aid in early risk assessment of early stage 1-3b CKD.

Surfing the Nash Tsunami
S3-E54 - AASLD 2022 Liver Meeting Live Coverage: Part 2

Surfing the Nash Tsunami

Play Episode Listen Later Nov 10, 2022 94:11


This week attendees from around the world convened at the 73rd Annual AASLD Liver Meeting  for a lively and momentous event in Washington DC. On the final morning, Stephen Harrison, Sven Francque, Jörn Schattenberg, Ian Rowe and Jeff McIntyre join Roger Green to discuss key takeaways. Sven is first to expand on a presentation that struck notable interest. He chooses to highlight a presentation by Laurent Castera, which Mazen Noureddin anticipated in our preview coverage. This focuses on a prospective head-to-head comparison of the different non-invasive tests in a large cohort of T2D patients with NAFLD. The paper concluded that F-AST and MAST scores outperformed MEFIB, FIB-4 and NFS for identifying fibrotic NASH in T2D patients with NAFLD. Stephen broadens Sven's analysis by noting F-AST as a standout test that is generally available for multiple different applications. The group puts forth commentary on the cost effectiveness and accuracy of these tests within enriched populations. As this subject winds down, Ian points to the particular challenge of selecting patients for treatment. The reality, he says, is that it's not a one size fits all approach. The conversation transitions from diagnostics to the topic of drugs. Stephen  walks through his presentation on the efficacy and safety of Akero's lead product candidate efruxifermin (EFX) in patients with clinically relevant NASH (F2-F3). The results point to EFX significantly improving liver histology, liver fat content and noninvasive markers of liver injury, fibrosis, and glucose and lipid metabolism in patients with F2/F3 fibrosis due to NASH. Stephen shares his optimism for this particular FGF-21 agonist while Sven agrees that “not all FGF-21's are created equal.” The group explores the science behind the structure of the EFX compound before Roger recalls the question of where the right use for such a drug might exist. It's been previously suggested on this podcast that a medication not entirely suited for long-term therapy due to cost, dosing or side effects might serve best as induction therapy. With this in mind, the group addresses the dynamics of what happens when disease regresses to a point where there is far less liver damage. From here, Roger introduces a brief assessment of Arun Sanyal's presentation of topline results from a new analysis of the REGENERATE Trial.The last major theme in this episode involves the Nomenclature session. Jeff offers an objective account of how this subject reported before disclosing some concerns from the patient perspective. His primary concern lies in coming to a decision that causes regulatory agencies to require new clinical trials, thereby slowing approvals by several years. The other panelists respond with their impressions and the consensus is that virtually nobody is in favor of a name change at this point in time if it stands in the way of progressing drugs and diagnostics.The breadth, quality and novelty of this conversation reflects yet another exceptional and positive Liver Meeting, this time back in person. In lieu of the typical business report, Roger and Stephen conduct a special interview with Michael Cooreman from Inventiva. The three discuss the work of this clinical-stage biopharmaceutical company and its relevance to Fatty Liver. Inventiva develops novel and differentiated oral small molecule therapies for patients suffering from diseases with significant unmet medical need. The discussion centers mostly around clinical trial development for the pan-PPAR lanifibranor.  

Type2Take2
What Causes YOUR Diabetes?!

Type2Take2

Play Episode Listen Later Nov 9, 2022 63:43


Hey there Health Visionaries! Today we are going to get into some science about how your diabetes works and why your body has it. We are also going back to the beginning with the book of Genesis to show where all death, sickness and disease began. Stick around for our 4 pillars or skip ahead to the health segment! In the health segment, we discuss: The Role of the Adamic SNAP and its Creation of the SNP Beta Cells and their role in the pancreas How to combat T2D through lifestyle adjustments Don't forget to share this podcast with the people who you love, like and respect so they can actually understand the WHY of their diabetes. Click my link down below to see all of the goodies I recommend as well as the books that I read! Envision Health

Surfing the Nash Tsunami
S3-E52.1 - FIB-4 and the Way Forward in Primary Care Screening

Surfing the Nash Tsunami

Play Episode Listen Later Nov 5, 2022 12:19


In a follow-up preview, Jörn Schattenberg, Louise Campbell, Mazen Noureddin, Ian Rowe and patient advocate Jeff McIntyre join Roger Green to discuss key presentations and posters of interest at the 73rd Annual Meeting of the American Association for the Study of Liver Diseases (AASLD). On November 4th-8th in Washington DC, as many as 10,000 attendees will convene in an effort to advance and disseminate the science and practice of hepatology, and to promote liver health and quality patient care.This conversation focuses on a presentation by Laurent Castera from Parallel Session 33 on Monday afternoon. The abstract looks to validate and compare head-to-head the FASTTM, MAST, and MEFIB scores as well as FIB-4 and NAFLD fibrosis score in a large cohort of T2D patients with NAFLD. Mazen points out that while the paper compares the various tests, the key is to ask which test is best for each specific purpose. In general, these results show that MAST and FAST perform better than the other three tests in terms of area under curve. Results also indicate that MAST has an indeterminate range of around 20%, as compared to 44% for FAST and MEFIB. The latter result suggests to Mazen that the researcher will need fewer biopsies to classify patients using MAST and MAST should score better on true classifications. Roger refers to last week's discussion around which test to use at different points in the patient screening process. Mazen notes that while he has concerns with FIB-4, it remains as one of the best primary test options today. He repeats Stephen Harrison's question from last week on whether we should start primary screening with FibroScan instead of FIB-4.As the session ends, Jörn suggests that the discussion on best clinical use will continue. He notes that the goal of this paper is to contribute to discussion around the value of each test, ‘the true task of academia.'

Surfing the Nash Tsunami
S3-E52 - Part 2: A Preview of the 2022 AASLD Liver Meeting

Surfing the Nash Tsunami

Play Episode Listen Later Nov 3, 2022 56:37


In a follow-up preview, Jörn Schattenberg, Louise Campbell, Mazen Noureddin, Ian Rowe and patient advocate Jeff McIntyre join Roger Green to discuss key presentations and posters of interest at the 73rd Annual Meeting of the American Association for the Study of Liver Diseases (AASLD). On November 4th-8th in Washington DC, as many as 10,000 attendees will convene in an effort to advance and disseminate the science and practice of hepatology, and to promote liver health and quality patient care.Mazen begins by highlighting a presentation by Laurent Castera which covers an abstract the two collaborated on. The paper looks to validate and compare head-to-head the FASTTM, MAST, and MEFIB scores as well as FIB-4 and NAFLD fibrosis score in a large cohort of T2D patients with NAFLD. Roger notes last week's discussion on use of FIB-4 as a primary screening tool, commending its performance in NPV but not PPV. He suggests this study offers a way forward for an enriched population who would benefit from a test offering high PPV and a narrow indeterminate zone. Jörn and Louise respond with their thoughts on FIB-4 as a cheap, accessible tool for primary care. Their analysis aligns with a conclusion from last week's preview: FIB-4 is not a tool for the specialist's office but, instead for primary care practices conducting first-line screening.Ian suggests some of the preceding conversation anchors performance of these tests to biopsy. Interested in moving beyond biopsy, he points out presentations which compare outcomes of patients according to either biopsy or associated noninvasive tests. The first paper investigates whether screening for advanced fibrosis in the community can identify the subgroup of people with NAFLD at higher risk for development of liver-related complications. The study aimed to determine the prognostic value of baseline noninvasive fibrosis tests for predicting liver-related outcomes and mortality in patients with NAFLD from T2D clinics or primary care. Ian then looks at a presentation by Samer Gawrieh which provides data on progression. Mazen agrees with the idea that as data accumulates around NITs, we can better understand how longitudinal changes impact outcomes.Jörn highlights his anticipation for Parallel 12: NASH therapeutics and OMICs. He specifically points to a presentation by Jonathan Stine on answering an unmet need to develop effective lifestyle intervention programs. This randomized proof of concept trial evaluates the feasibility, acceptability and safety of a novel commercially available mobile health app. This topic immediately resonates with Jeff, who is encouraged by two elements: the development of remote personalized technologies and the resulting patient empowerment. Roger raises questions around the commercial model buttressing this study: who is paying and for how long can they maintain motivation? He envisions a more viable approach will be supported by commercial payers, who in return are investing in health care data. Given this may take some time to play out, Roger casts a third suggestion: FDA-approved digital therapeutic apps. He predicts this to be fertile grounds for patient empowerment over the next few years. After some back and forth with Jeff, Roger shifts focus to his interest in posters on primary care screening and the metabolic-NAFLD link. Mazen shares his enthusiasm for the potential of machine learning to ensure accuracy in the use of NITs.As time winds down, the panelists provide closing comments touching on a number of topics. It's noted that this data-rich, insight-laden conference will host a dynamic inclusion of presentations on therapeutics, drug development and solutions deployed to market. Stay tuned for the upcoming live recorded coverage from Washington DC.

Pharmacy Podcast Network
Simple steps to getting your patients with diabetes started on CGM | Real-Time Real Talk™ by Dexcom™

Pharmacy Podcast Network

Play Episode Listen Later Nov 1, 2022 39:08


Disclaimer: This podcast is not approved for CME credit. Every diabetes treatment plan is different, individual results may vary – nothing you hear on this podcast should be considered medical advice. All claims are supported by clinical evidence referenced in the show notes. For clinical study results, please refer to the Dexcom G6 User Guide. For product-related questions, please refer to the instructions for use. For complete safety information, go to dexcom.com/safety-information. Smart devices are sold separately. For a list of compatible smart devices, visit: dexcom.com/compatibility.   Fingersticks required for diabetes treatment decisions if symptoms or expectations do not match readings.   Data from collaborator devices and products must be verified by those collaborator devices and products. Users should confirm data and connections with their collaborator devices and products. The Dexcom G6 Continuous Glucose Monitoring System (Dexcom G6 System) is a real time, continuous glucose monitoring device indicated for the management of diabetes in persons aged 2 years and older. Scott Urquhart is a paid spokesperson for Dexcom. Dr. Urquhart is a guest on this episode of the podcast. Dexcom G6 is covered for 3 out of 4 patients with T2D on mealtime insulin with commercial health insurance plans.*  Dexcom G6 System User Guide   Safety Information   About Hello Dexcom   About SIGMA   Dexcom Follow app: The Dexcom G6 App allows you to share your glucose data with up to 10 people. By downloading the Dexcom Follow App, followers can view your glucose data directly from their smart devicewhether they live down the street or across the country. Separate Follow App required. For a list of compatible devices, visit www.dexcom.com/compatibility.   Connectivity – basics (https://provider.dexcom.com/dexcom-cgm/collaborators) Time in Range: Recommendations from the International Consensus on Time in Range, 2019 recommend individualized glycemic targets for high risk and/or older adults with a focus on reducing the percentage of time spent less than 70 md/dL and preventing excessive hyperglycemia. Everyone's treatment plan is different, talk to your healthcare provider before changing your Time in Range settings. Brief Safety Statement Failure to use the Dexcom G6 Continuous Glucose Monitoring System (G6) and its components according to the instructions for use provided with your device and available at https://www.dexcom.com/safety-information and to properly consider all indications, contraindications, warnings, precautions, and cautions in those instructions for use may result in you missing a severe hypoglycemia (low blood glucose) or hyperglycemia (high blood glucose) occurrence and/or making a treatment decision that may result in injury. If your glucose alerts and readings from the G6 do not match symptoms or expectations or you're taking over the recommended maximum dosage amount of 1000mg of acetaminophen every 6 hours, use a blood glucose meter to make diabetes treatment decisions. Seek medical advice and attention when appropriate, including for any medical emergency. The web-based Dexcom CLARITY software is intended for use by both home users and healthcare professionals to assist people with diabetes and their healthcare professionals in the review, analysis, and evaluation of historical CGM data to support effective diabetes management. It is intended for use as an accessory to Dexcom CGM devices with data interface capabilities. Caution: The software does not provide any medical advice and should not be used for that purpose. Home users must consult a healthcare professional before making any medical interpretation and therapy adjustments from the information in the software. Caution: Healthcare professionals should use information in the software in conjunction with other clinical information available to them. Caution: Federal (US) law restricts this device to sale by or on the order of a licensed healthcare professional. Dexcom, Dexcom Follow, Dexcom CLARITY, and Dexcom Share are registered trademarks of Dexcom, Inc. in the U.S., and may be registered in other countries. References: Beck RW, Riddlesworth T, Ruedy K, et al. Effect of Continuous Glucose Monitoring on Glycemic Control in Adults With Type 1 Diabetes Using Insulin Injections:The DIAMOND Randomized Clinical Trial. 2017;317(4):371–378. doi:10.1001/jama.2016.19975 William H. Polonsky, Danielle Hessler, Katrina J. Ruedy, Roy W. Beck; for the DIAMOND Study Group, The Impact of Continuous Glucose Monitoring on Markers of Quality of Life in Adults With Type 1 Diabetes: Further Findings From the DIAMOND Randomized Clinical Trial.Diabetes Care 1 June 2017; 40 (6): 736–741. https://doi.org/10.2337/dc17-0133 Martens T, Beck RW, Bailey R, et al. Effect of Continuous Glucose Monitoring on Glycemic Control in Patients With Type 2 Diabetes Treated With Basal Insulin:A Randomized Clinical Trial.  2021;325(22):2262–2272. doi:10.1001/jama.2021.7444 William H. Polonsky, PhD,1,2 Emily C. Soriano, PhD,3 and Addie L. Fortmann, PhD3 The Role of Retrospective Data Review in the Personal Use of Real-Time Continuous Glucose Monitoring: Perceived Impact on Quality of Life and Health Outcomes Vigersky RA, McMahon C. The relationship of hemoglobin A1C to time-in-range in patients with diabetes. Diabetes Technol Ther 2019;21:81–85.

Endocrine News Podcast
ENP56 Reposted: Gestational Diabetes, Maternity Blues, and T2D

Endocrine News Podcast

Play Episode Listen Later Nov 1, 2022 11:20


This is a re-posting of Episode 56 due to audio problems with the original posting. In this episode, Aaron talks with Jennifer Dias from the Icahn School of Medicine at Mount Sinai about gestational diabetes, its association with postpartum depressive symptoms ("maternity blues"), and a predictor that may help prevent gestational diabetes from developing into type 2 diabetes. Ms. Dias, an MD candidate, presented research at ENDO 2022 titled, "Predictors of Postpartum Depressive Symptoms in Women with Recent GDM." For more information, including helpful links and other episodes, visit our website at https://www.endocrine.org/podcast.

Inside Exercise
Exercise and insulin action with Dr Jorgen Wojtaszewski

Inside Exercise

Play Episode Listen Later Oct 27, 2022 60:26


Dr Glenn McConell chats with Professor Jorgen Wojtaszewski from the University of Copenhagen. Jorgen has an exceptional track record of research examining how exercise increases glucose uptake during the exercise and how exercise increases the sensitivity of muscle to insulin. We discuss insulin resistance, insulin sensitivity, type 1 diabetes and exercise, type 2 diabetes and exercise, glucose uptake during exercise, glucose uptake after exercise, best exercise to increase insulin action, gender effects, aging effects etc. Also the likelihood of developing a drug to mimic exercise's effect of insulin sensitivity. 0:00. Introduction and how he got into the area 2:47. Exercise, insulin and insulin after exercise 5:00. Exercise, insulin and type 1 diabetes. Historical factors re exercise and insulin 8:50. Exercise and type 2 diabetes 13:54. Better to prevent diabetes than treat 15:00. Mechanisms that exercise increases insulin action One bout (acute) of exercise vs exercise training (chronic) 20:00. Each bout of exercise increases insulin sensitivity For 24-48 hrs. 22:13. Best exercise to increase insulin action 24:11. Glycogen use during exercise and insulin action 27:20. Acute exercise after exercise training Is there an upper limit to insulin sensitivity of muscle. 29:26. Researchers usually involve well controlled people with T2D Can we assume we'd get the same results if involved people with T2D on medications etc. 31:00. Struggles/failures in the lab Winston Churchill. “Going from failure to failures without losing enthusiasm”. Be open to learn from mistakes. 33:22. Story telling in science Stick with original introduction/rationale. Problem of lack of hypotheses. So called “negative findings”. 37:12. Sex differences 39:52. Aging effects Possibly due to less physically active. Same with T2D, tend to be less PA. 41:45. How know if insulin sensitive? 45:05. Variability between individuals 48:02. Personalized phosphorylation of proteins Application to insulin resistance. Also cancer. 52:02. Insulin resistance central to many diseases Chicken or the egg? 53:45. Possibility of an exercise pill and would it be safe? AMP-activated protein kinase (AMPK)!specifically. Possibly eventually a treatment but not a cure. 58:22. Take home messages. Inside Exercise brings to you the who's who of exercise metabolism, exercise physiology and exercise's effects on health. With scientific rigor, these researchers discuss popular exercise topics while providing practical strategies for all. The interviewer, Emeritus Professor Glenn McConell, has an international research profile following 30 years of Exercise Metabolism research experience while at The University of Melbourne, Ball State University, Monash University, the University of Copenhagen and Victoria University. He has published over 120 peer reviewed journal articles and recently edited an Exercise Metabolism eBook written by world experts on 17 different topics (https://link.springer.com/book/10.1007/978-3-030-94305-9). Connect with Inside Exercise and Glenn McConell at: Twitter: @Inside_exercise and @GlennMcConell1 Instagram: insideexercise Facebook: Glenn McConell LinkedIn: Glenn McConell https://www.linkedin.com/in/glenn-mcconell-83475460 ResearchGate: Glenn McConell Email: glenn.mcconell@gmail.com Subscribe to Inside exercise: Spotify Apple Podcasts: https://podcastsconnect.apple.com/my-podcasts/show/inside-exercise/03a07373-888a-472b-bf7e-a0ff155209b2 YouTube: https://youtube.com/channel/UChQpsAQVEsizOxnWWGPKeag Google Podcasts Anchor Podcast addict etc

Ask the Experts: It's Personal
Ask the Experts: Eating healthy, exercising regularly and monitoring glucose - does that really help?

Ask the Experts: It's Personal

Play Episode Listen Later Oct 26, 2022 64:46


Audience called in and asked questions of our experts regarding how diet and exercise impact one's diabetes health outcomes. Register for our next LIVE Q&A event at diabetes.org/experts or by calling 1-800-DIABETES.

Keeping Current CME
Novel Once-Weekly Basal Insulins: Expert Interpretation of Latest Clinical Data

Keeping Current CME

Play Episode Listen Later Oct 26, 2022 24:30


Newer oral glucose-lowering agents have revolutionized the treatment of type 2 diabetes (T2D), yet up to 40% of people across the globe still require insulin. Credit available for this activity expires: 10/18/2023 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/982624?src=mkm_podcast_series_982624

Boundless Body Radio
Insulin Resistance Explained with Jeff Cyr! 352

Boundless Body Radio

Play Episode Play 22 sec Highlight Listen Later Oct 14, 2022 73:39


Check out our new Patreon page! Get access to the Boundless Body Radio Premium Podcast, with a new episode added every other week! Other perks include early releases of our episodes, extended video content, and group and one on one coaching!Jeff Cyr has an incredible journey of failing and recovering health. He ended up getting a diagnosis of severe lumbar spinal stenosis in the 1990's and had a challenging time walking because of his permanent nerve damage. Most of the day, Jeff would sit in his La-Z-Boy, and at 330 pounds, Jeff would need to use his cane to get out of the chair. Jeff was eventually diagnosed with type 2 diabetes. They gave Jeff a nutritionist who told him to eat a high-carb diet of whole grains and fruits. In 2008, Jeff finally stopped feeling sorry for himself, and he knew something had to change. So, Jeff stopped smoking cold turkey, quit oral morphine cold turkey, and started exercising at a local gym. On the first day of exercising, Jeff rode the bike for two minutes. Each day, Jeff would increase the time on his bike. Over the course of sixteen months, Jeff lost 163 pounds, and eventually leveraged a low carbohydrate, ketogenic diet to improve his health. Now he is an expert in helping others to use low carbohydrate diets to reverse the same chronic diseases that he had to suffer through!Find Jeff at-FB- @Jeff CyrFind Boundless Body at-myboundlessbody.comBook a session with us here! Find Boundless Body at- myboundlessbody.com Book a session with us here! Check out our new Patreon page!

Fitness Confidential with Vinnie Tortorich
BEST OF: Becoming Undoctored with Dr. William Davis - Episode 2210

Fitness Confidential with Vinnie Tortorich

Play Episode Listen Later Oct 12, 2022 68:12 Very Popular


Episode 2210 - BEST OF: On this special edition of the Wednesday show, we replay episode 838 when Vinnie Tortorich welcomes back Dr. William Davis to discuss his book "", the state of the healthcare industry, becoming undoctored, the effects of grains and sugars on your body, and more. https://vinnietortorich.com/best-of-becoming-undoctored-dr-william-davis-epsiode-2210 PLEASE SUPPORT OUR SPONSORS BECOMING UNDOCTORED Vinnie welcomes Dr. William Davis who is a prominent cardiologist and also the author of "Wheat Belly". (2:00) Dr. Davis gives his own backstory of when he was in med school and the effects of the lifestyle and food that was available. (4:00) Vinnie and William discuss how diet is so important and the dietary guidelines are just bad! (8:00) All the grains that are promoted are to blame for T2D and autoimmune disorders. Many vitamin and mineral deficiencies happen because grains affect absorption and gut and bowel flora. (9:45) William then gives the reason behind writing his book "Undoctored". (10:30) Vinnie asks William where the idea of fiber and grains being beneficial to the bowel originated. (14:00) They also discuss how inflammation affects the body; Vinnie explains what would happen during his ultra racing. (20:25) William gives his thoughts on inflammation and toxins. Many prescribed medications for inflammation could be reduced if there weren't grain consumption. (22:50) They then discuss cholesterol and the myth behind it. (30:00) William talks about LDL and particle size and what it means. Vinnie shares his experience with cancer and what he was advised to do by his doctor. (35:00) William agrees that ketosis appears to be one of the best ways to avert cancer and encourage remission. MANAGING YOUR HEALTH They chat about how there are ways with tech and other resources for people to manage their own health better. (39:30) Vinnie and William chat about particle tests and statins. (46:15) William explains why parts of the cholesterol test aren't even an accurate measurement. Many doctors are motivated by money. (49:30) Because the sugar industry controls so much, often doctors become pariahs if they speak out against sugar and grain. An example is the treatment of Dr. Tim Noakes in South Africa when he was actually treating people and getting them healthy. (51:00) Dr. Davis tries to uncover the truths behind that in his new book. Health is a basic right. The grain industry has hired PR firms to discredit Dr. Davis. They also discuss several prominent vegan doctors. (56:00) William summarizes steps you can take for better health that he discusses in his "Undoctored" book as well. (1:01:10) Dr. Davis also discusses some of the books in his series, including cookbooks as well. (1:04:00) [the_ad id="20253"] PURCHASE BEYOND IMPOSSIBLE The documentary launched on January 11! Order it TODAY! This is Vinnie's third documentary in just over three years. Get it now on Apple TV (iTunes) and/or Amazon Video! Link to the film on Apple TV (iTunes):  Then, Share this link with friends, too! It's also now available on Amazon (the USA only for now)!  Visit my new Documentaries HQ to find my films everywhere:   REVIEWS: Please submit your REVIEW after you watch my films. Your positive REVIEW does matter! FAT: A DOCUMENTARY 2 (2021) Visit my new Documentaries HQ to find my films everywhere: Then, please share my fact-based, health-focused documentary series with your friends and family. The more views, the better it ranks, so please watch it again with a new friend! REVIEWS: Please submit your REVIEW after you watch my films. Your positive REVIEW does matter! FAT: A DOCUMENTARY (2019) Visit my new Documentaries HQ to find my films everywhere: Then, please share my fact-based, health-focused documentary series with your friends and family. The more views, the better it ranks, so please watch it again with a new friend! REVIEWS: Please submit your REVIEW after you watch my films. Your positive REVIEW does matter!  

ReachMD CME
Beyond A1c: Practical Strategies for Managing Obesity in Patients with T2D

ReachMD CME

Play Episode Listen Later Sep 28, 2022


CME credits: 0.25 Valid until: 28-09-2023 Claim your CME credit at https://reachmd.com/programs/cme/beyond-a1c-practical-strategies-for-managing-obesity-in-patients-with-t2d/14131/ There are now multiple medical therapies available to facilitate weight loss in patients with type 2 diabetes (T2D). Learn who is the right patient, when these therapies should be started, and the right combinations and intensification strategies to sustain meaningful weight loss that can lower the risk of complications.

Inside Exercise
Heat therapy, exercise and chronic disease with Dr Paige Geiger

Inside Exercise

Play Episode Listen Later Sep 23, 2022 66:06


Dr Glenn McConell chats with Professor Paige Geiger from the University of Kansas Medical Centre on Heat therapy, exercise and chronic disease. Paige has undertaken very important mechanistic and allied work in this field. We discussed many things (see time stamps below). 0:00. Introduction how got into the area 6:26. How first idea to look at heat and diabetes Phil Hooper in 1999 put people with T2D in hot tubs 9:00. Heat shock proteins (HSPs) Activated by many stresses in addition to heat. Many roles. 10:53. High fat diets and heat Need to raise body temp by 1C 14:22. Body temp increases during exercise Some of the benefits/adaptations from exercise may be activation of HSPs 16:26. Preconditioning and HSPs 17:49. Separating the effects of exercise from heat Additive effect of exercise and heat? 20:54. Q10 effect, exercise and HSPs? 22:27. HSPs with heat vs exercise 25:54. Ideal heat therapy dose Temperature, time, number of sessions. 29:55. Why not just exercise? Not everyone can exercise. 32:22. Heat therapy for chronic diseases 35:08. Sauna vs hot tub 36:58. Higher core temp vs heating muscle 38:40. Heat and myokines/exosomes 40:33. What's turning on HSPs Heat shock factor 1 etc. 43:52. Heat therapy and the mitochondria/insulin sensitivity 49:35. How often need heat therapy? 51:34. Does everyone respond to heat? 52:45. Is heat therapy appropriate for all? 54:13. Aging and heat therapy 55:23. Heat having effects in addition to HSPs? 56:49. Troubleshooting in the lab 59:14. HSPs, exercise and the liver 1:01:56. Too much comfort? Inside Exercise brings to you the who's who of exercise metabolism, exercise physiology and exercise's effects on health. With scientific rigor, these researchers discuss popular exercise topics while providing practical strategies for all. The interviewer, Emeritus Professor Glenn McConell, has an international research profile following 30 years of Exercise Metabolism research experience while at The University of Melbourne, Ball State University, Monash University, the University of Copenhagen and Victoria University. He has published over 120 peer reviewed journal articles and recently edited an Exercise Metabolism eBook written by world experts on 17 different topics (https://link.springer.com/book/10.1007/978-3-030-94305-9). Connect with Inside Exercise and Glenn McConell at: Twitter: @Inside_exercise and @GlennMcConell1 Instagram: insideexercise Facebook: Glenn McConell LinkedIn: Glenn McConell https://www.linkedin.com/in/glenn-mcconell-83475460 ResearchGate: Glenn McConell Email: glenn.mcconell@gmail.com Subscribe to Inside exercise (below plus most other platforms too) Spotify: https://open.spotify.com/show/3pSYnNSXDkNLH8rImzotgP?si=Whw_ThaERF6iIKwxutDoNAApple Podcast: https://podcastsconnect.apple.com/my-podcasts/show/inside-exercise/03a07373-888a-472b-bf7e-a0ff155209b2 Google Podcasts: https://podcasts.google.com/feed/aHR0cHM6Ly9hbmNob3IuZm0vcy84ZTdiY2ZkMC9wb2RjYXN0L3Jzcw Anchor: https://anchor.fm/insideexercise Podcast Addict: https://podcastaddict.com/podcast/4025218YouTube: https://youtube.com/channel/UChQpsAQVEsizOxnWWGPKeag

The Gary Null Show
The Gary Null Show - 09.20.22

The Gary Null Show

Play Episode Listen Later Sep 21, 2022 63:09 Very Popular


Videos: The Truth About Ivermectin: A new short documentary by Filmmaker Mikki Willis – 13:42 Neil Oliver: This supposed utopia we're having rammed down our throats isn't working – 9:58 New Rule: Cancel Culture is Over Party | Real Time with Bill Maher (HBO) – 6:45   Antioxidants protect against cartilage damage Skeletal Biology and Engineering Research Center (Belgium), September 12 20228. An article appearing in Science Translational Medicine adds evidence to the role of antioxidants in protecting the body's cartilage from the damage that contributes to osteoarthritis. Acting on the finding that the protein ANP32A, which is involved in a number of processes in the body, was downregulated in osteoarthritic cartilage in mice and humans, Frederique Cornelis of the Skeletal Biology and Engineering Research Center in Belgium and colleagues discovered that ANP32A protects against oxidative damage in the joints, thereby helping to prevent the development of osteoarthritis and its progression. It was determined that ANP32A increases levels of the enzyme ATM, a regulator of the cellular oxidative defense, in response to oxidative stress in joint cartilage. The discovery suggests that antioxidant therapies could help protect against further damage in patients with osteoarthritis, as well as providing a benefit in other disorders. Administration of the antioxidant N-acetylcysteine (NAC) to the drinking water of mice that were deficient in ANP32A was shown to decrease cartilage damage and arthritis symptoms. It was additionally revealed that ANP32A deficiency was associated with osteopenia and a neurologic disease known as cerebellar ataxia in mice and that NAC helped with these conditions. “Aging, a key risk factor for the development of osteoarthritis, is associated with elevated oxidative damage of DNA, proteins, and lipids, and accumulating evidence indicates that oxidative stress is a major physiological inducer of aging,” the authors write. “We observed reduced expression of ANP32A in aged mouse cartilage and in human cartilage from patients with osteoarthritis, and we showed that Anp32a-deficient mice develop spontaneous osteoarthritis upon aging. Thus, ANP32A can be considered as a key coordinator of oxidative stress and aging in joints.” “Our findings indicate that modulating ANP32A signaling could help manage oxidative stress in cartilage, brain, and bone with therapeutic implications for osteoarthritis, neurological disease, and osteoporosis,” they conclude. Consuming Soy Peptide May Reduce Colon Cancer Metastasis University of Illinois, September 18, 2022 After a recent University of Illinois study showed that injection of the soy peptide lunasin dramatically reduced colon cancer metastasis in mice, the researchers were eager to see how making lunasin part of the animals' daily diet would affect the spread of the disease. “In this new study, we find that giving lunasin orally at 20 mg/kg of body weight reduced the number of metastatic tumors by 94 percent — we went from 18 tumors to only one. And that was done using lunasin alone; no other type of therapy was used,” said Elvira de Mejia, a U of I professor of food chemistry and food toxicology. “We learned in that study that lunasin can penetrate the cancer cell, cause cell death, and interact with at least one type of receptor in a cell that is ready to metastasize,” said Vermont Dia, a postdoctoral associate in the de Mejia laboratory. Using mice that had been injected with human colon cancer cells, the scientists began by feeding the animals 8 mg/kg of lunasin daily, which reduced the number of new tumors in the liver by 55 percent. They increased the dose five times, at last achieving a 94 percent reduction in tumors at 20 mg/kg of lunasin. “We were very impressed by the reduction, but the results were short of statistical significance from the control group. More animals are needed to strengthen the power of the analysis. It's a small study but very promising,” de Mejia said. The scientists said that consuming the equivalent of 20 to 30 mg/kg of lunasin in soy foods would be daunting in terms of number of servings per day. “But it would certainly be possible if food companies began to offer lunasin-enriched soy milk or yogurt,” she said, noting that lunasin-enriched flour is already on the market. Globally, diets are not much healthier today than they were thirty years ago Tufts University, September 19, 2022 On a scale from 0 to 100 of how well people stick to recommended diets, with 0 being a poor diet (think heavy consumption of sugar and processed meats), and 100 representing the recommended balance of fruits, vegetables, legumes/nuts and whole grains, most countries would earn a score around 40.3. Globally, this represents a small, but meaningful, 1.5-point gain between 1990 and 2018, researchers from the Friedman School of Nutrition Science and Policy at Tufts University report today in the journal Nature Food. The study, one of the most comprehensive estimates yet of global dietary quality—and the first to include findings among children as well as adults—highlights the challenges worldwide to encourage healthy eating. Although global gains were modest, there was notable variation by country, with nutritious options becoming more popular in the United States, Vietnam, China, and Iran, and less so in Tanzania, Nigeria, and Japan. “Intake of legumes/nuts and non-starchy vegetables increased over time, but overall improvements in dietary quality were offset by increased intake of unhealthy components such as red/processed meat, sugar-sweetened beverages, and sodium,” says lead author Victoria Miller, a visiting scientist from McMaster University in Canada who started this study as a postdoctoral scholar with Dariush Mozaffarian, Dean for Policy and Jean Mayer Professor of Nutrition at the Friedman School, and senior author on the paper. Miller and colleagues addressed this gap by measuring global, regional, and national eating patterns among adults and children across 185 countries based on data from over 1,100 surveys from the Global Dietary Database, a large, collaborative compilation of data on food and nutrient consumption levels worldwide. The researchers' primary outcome was the 0 to 100 scale known as the Alternative Healthy Eating Index, a validated measure of diet quality. Regionally, averages ranged from as low as 30.3 in Latin America and the Caribbean to as high as 45.7 in South Asia. The average score of all 185 countries included in the study was 40.3. Only 10 countries, representing less than 1 percent of the world's population, had scores over 50. The world's highest scoring countries were Vietnam, Iran, Indonesia and India, and the lowest scoring were Brazil, Mexico, the United States and Egypt. Globally, among adults, women were more likely to eat recommended diets than men, and older adults more so than younger adults. Yogic breathing shows promise in reducing symptoms of post-traumatic stress disorder University of Wisconsin-Madison September 11, 2022 One of the greatest casualties of war is its lasting effect on the minds of soldiers. This presents a daunting public health problem: More than 20 percent of veterans returning from the wars in Iraq and Afghanistan have post-traumatic stress disorder, according to a report by RAND Corp. A new study from the Center for Investigating Healthy Minds at the Waisman Center of the University of Wisconsin-Madison offers hope for those suffering from the disorder. Researchers there have shown that a breathing-based meditation practice called Sudarshan Kriya Yoga can be an effective treatment for PTSD. Standard treatment interventions for PTSD offer mixed results. Some individuals are prescribed antidepressants and do well while others do not; others are treated with psychotherapy and still experience residual affects of the disorder. Sudarshan Kriya Yoga is a practice of controlled breathing that directly affects the autonomic nervous system. While the practice has proven effective in balancing the autonomic nervous system and reducing symptoms of PTSD in tsunami survivors, it has not been well studied until now. The CIHM team was interested in Sudarshan Yoga because of its focus on manipulating the breath, and how that in turn may have consequences for the autonomic nervous system and specifically, hyperarousal. Theirs is the first randomized, controlled, longitudinal study to show that the practice of controlled breathing can benefit people with PTSD. The CIHM study included 21 soldiers: an active group of 11 and a control group of 10. Those who received the one-week training in yogic breathing showed lower anxiety, reduced respiration rates and fewer PTSD symptoms. Cognition May Decline With Old Age, But Well-Being Actually Improves University of California, San Diego School of Medicine, September 19, 2022 Children and adolescents usually want to grow up as soon as possible, but most older adults will say they want nothing more than to turn back the clock. Research out of the University of California, San Diego School of Medicine gives both the old and the young reason to envy each other. Scientists say that while older adults usually see a decline in thinking skills, well-being typically increases as we grow older. More specifically, scientists report that healthy older adults display greater mental well-being than younger adults, but also score lower on cognitive performances. The UCSD team is hopeful that the underlying neural mechanisms identified during this project contributing may inspire new interventions to promote healthy brain function in the future. Researchers sampled a total of 62 healthy younger adults in their 20s, and 54 healthy older adults over 60. Each subject's mental health was measured via a survey asking about symptoms including anxiety, depression, loneliness, and overall mental wellbeing. Participants also took part in a series of cognitively demanding tasks, all while their brain activity was measured using electroencephalography (EEG). Results show that young adults experience far more anxiety, depression, and loneliness than older adults. On the other hand, older individuals show higher levels of well-being. Regarding cognition, older adults, unsurprisingly, were much weaker. The EEG recordings provided further insight, detailing greater activity in the anterior portions of the brain's default mode network among older adults. This brain area is active when we ruminate, daydream, etc., and is usually suppressed during goal-oriented tasks. Notably, several other brain regions appeared to improve cognition. Strong cognitive scores among young adults were associated with more activity in the dorsolateral prefrontal cortex, which is part of the brain's executive control system. For older adults, though, those with strong cognitive scores actually displayed greater activity in their inferior frontal cortex, a brain region known to help guide attention and avoid distractions. The dorsolateral prefrontal cortex is known to break down as the body ages. Consequently, researchers theorize that the increased inferior frontal cortex activity among cognitively strong older individuals may be an avenue for older minds to compensate during mentally tougher tasks. Drinking plenty of tea may reduce the risk of developing type 2 diabetes, finds study in over a million adults Wuhan University of Science and Technology (China), September 17, 2022 A systematic review and meta-analysis of 19 cohort studies involving more than 1 million adults from eight countries finds that moderate consumption of black, green or Oolong tea is linked to a lower risk of developing type 2 diabetes. The findings, being presented at this year's European Association for the Study of Diabetes (EASD) Annual Meeting in Stockholm, Sweden suggest that drinking at least four cups of tea a day is associated with a 17% lower risk of T2D over an average period of 10 years. While it's long been known that regularly drinking tea may be beneficial for health because of the various antioxidant, anti-inflammatory and anticarcinogenic compounds tea contains, less clear has been the relationship between tea drinking and the risk of T2D. So far, published cohort studies and meta-analyses have reported inconsistent findings. Overall, the meta-analysis found a linear association between tea drinking and T2D risk, with each cup of tea consumed per day reducing the risk of developing T2D by around 1%. When compared with adults who didn't drink tea, those who drank 1-3 cups daily lowered their risk of T2D by 4%, while those who consumed at least 4 cups every day reduced their risk by 17%. The associations were observed regardless of the type of tea participants drank, whether they were male or female, or where they lived, suggesting that it may be the amount of tea consumed, rather than any other factor, that plays a major role. “While more research needs to be done to determine the exact dosage and mechanisms behind these observations, our findings suggest that drinking tea is beneficial in reducing the risk of type 2 diabetes, but only at high doses (at least 4 cups a day)”, says Li. She adds, “It is possible that particular components in tea, such as polyphenols, may reduce blood glucose levels, but a sufficient amount of these bioactive compounds may be needed to be effective. It may also explain why we did not find an association between tea drinking and type 2 diabetes in our cohort study, because we did not look at higher tea consumption.”

Inside Exercise
Exercise and type 2 diabetes with Dr John Hawley

Inside Exercise

Play Episode Listen Later Sep 15, 2022 62:17


Dr Glenn McConell chats with Professor John Hawley from the Australian Catholic University on Exercise and type 2 diabetes. John is one of the most recognized names in exercise metabolism. He has published over 300 journal articles (Google scholar: 40,000 citations, H index 113). We discussed many things (see time stamps below). 0:00. Introduction 1:34. Putting exercise and diet ahead of medical interventions 4:52. John's background / the All blacks 6:14. Acute exercise in type 2 diabetes 8:28. Exercise snacking 11:16. Intensity of exercise HIIT exercise increases glucose levels. 12:29. Don't complicate it, just exercise 14:34. Take the stairs 17:02. Muscle glucose uptake normal during exercise in T2D 18:44. Genes haven't changed environment has 21:45. Most diets unsuccessful 24:43. Time restricted eating 27:20. Continuous glucose monitoring 29:17. Circadian biology messed up 32:53. No national food guidelines consider the timing of meals 33:58. Inactivity and exercise resistance 34:53. Not a fan of intermittent/prolonged fasting 37:33. It's an individual thing 38:00. Timing of exercise 39:07. Assessing glucose control over the day 45:58. Exercise and insulin sensitivity 50:28. What would be your dream study? 53:01. Most studies do not involve typical people with T2D 55:04. Need to stick to it, not quick fix 56:31. Mechanisms of exercise vs diet Inside Exercise brings to you the who's who of exercise metabolism, exercise physiology and exercise's effects on health. With scientific rigor, these researchers discuss popular exercise topics while providing practical strategies for all. The interviewer, Emeritus Professor Glenn McConell, has an international research profile following 30 years of Exercise Metabolism research experience while at The University of Melbourne, Ball State University, Monash University, the University of Copenhagen and Victoria University. He has published over 120 peer reviewed journal articles and recently edited an Exercise Metabolism eBook written by world experts on 17 different topics (https://link.springer.com/book/10.1007/978-3-030-94305-9). Connect with Inside Exercise and Glenn McConell at: Twitter: @Inside_exercise and @GlennMcConell1 Instagram: insideexercise Facebook: Glenn McConell LinkedIn: Glenn McConell https://www.linkedin.com/in/glenn-mcconell-83475460 ResearchGate: Glenn McConell Email: glenn.mcconell@gmail.com Subscribe to Inside exercise: Spotify: https://open.spotify.com/show/3pSYnNSXDkNLH8rImzotgP?si=Whw_ThaERF6iIKwxutDoNA Apple Podcast: https://podcastsconnect.apple.com/my-podcasts/show/inside-exercise/03a07373-888a-472b-bf7e-a0ff155209b2 Google Podcasts: https://podcasts.google.com/feed/aHR0cHM6Ly9hbmNob3IuZm0vcy84ZTdiY2ZkMC9wb2RjYXN0L3Jzcw Anchor: https://anchor.fm/insideexercise Podcast Addict: https://podcastaddict.com/podcast/4025218 YouTube: https://youtube.com/channel/UChQpsAQVEsizOxnWWGPKeag

Boundless Body Radio
Passion in Low-Carb Healthcare with Dr. Evelyne Bourdua-Roy!

Boundless Body Radio

Play Episode Play 26 sec Highlight Listen Later Aug 29, 2022 67:28


Check out our new Patreon page! Get access to the Boundless Body Radio Premium Podcast, with a new episode added every other week! Other perks include early releases of our episodes, extended video content, and group and one on one coaching!Dr. Evelyne Bourdua-Roy is a family medicine doctor, who is also board-certified in Obesity Medicine by the American Board of Obesity Medicine (ABOM). Additionally, she has trained with Dr. Jason Fung and Megan Ramos in Toronto at their Intensive Dietary Management clinic. She has trained with Dr. Georgia Ede on the ketogenic diet and has authored several best-selling books in Quebec in French, with the first volume being translated into English, under the title Eat Fat to Lose Weight with the Keto and Low-Carb Diet. In January of 2017, Dr. Bourdua-Roy founded Clinique Reversa, which is a not-for-profit metabolic program that aims to help patients reverse their lifestyle-related chronic diseases. This program is led by a multidisciplinary team made up of several medical professionals, under Dr. Bourdua-Roy's supervision. She blogs for Diet Doctor when time permits, and has written several articles for other media outlets, including La Nutrition.Find Dr. Bourdua-Roy at-Clinique ReversaDr. Evelyne Bourdua-Roy's Books (Mostly in French)!TW- @CliniqueReversaFind Boundless Body at-myboundlessbody.comBook a session with us here! 

The NACE Clinical Highlights Show
Sponsored Content - The 411 on a GLP-1; Episode 2 - How to Empower Patients with T2D Knowledge and Introduce a GLP-1 RA

The NACE Clinical Highlights Show

Play Episode Listen Later Aug 29, 2022 36:53


Podcast Series Title: The 411 on a GLP-1Podcast Series Description: Join series host Dr. Jim Gavin, Clinical Professor of Medicine at Emory University and Chief Medical Officer for Healing our Village in Atlanta, Georgia, and fellow leaders in the field of diabetes as they tackle some of the challenges we face when treating T2D. Topics of discussion include clinical inertia, as well as the mechanism of action, dosing, efficacy, and safety of a GLP-1 RA for adults with T2D.Episode Title: How to Empower Patients with T2D Knowledge and Introduce a GLP-1 RAEpisode Description: What do you need to know about a once-daily GLP-1 RA and what can you do to help your patients taking this T2D therapy? Join this multidisciplinary discussion with Jim Gavin, MD; Curtis Triplitt, PharmD; and Jeffrey Unger, MD, as they review the mechanism of action, dosing, efficacy, and safety of a once-daily GLP-1 RA for adult patients with T2D. This program is intended for clinicians. The information presented is aligned with the views and opinions of the speakers and is sponsored by Novo Nordisk. This podcast is not to be used as medical advice and is intended for educational purposes only.Faculty Presenters:James R. Gavin III, MD, PhDClinical Professor of Medicine, Emory UniversityChief Medical Officer, Healing Our Village, Inc.Atlanta, GeorgiaJeff Unger, MD, FAAFP, FACEDiplomate, American Board of Family PracticeAssistant Clinical Professor of Family Medicine, UC Riverside School of MedicineRiverside, CaliforniaDirector, Unger Concierge Primary Care Medical GroupRancho Cucamonga, CaliforniaCurtis L. Triplitt, PharmD, CDCES, FADCESClinical Associate Professor of Medicine Division of DiabetesUniversity of Texas Health at San AntonioTexas Diabetes Institute, part of the University Health SystemSan Antonio, Texas

Fitness Confidential with Vinnie Tortorich
Success-in-Progress - Episode 2177

Fitness Confidential with Vinnie Tortorich

Play Episode Listen Later Aug 27, 2022 29:51 Very Popular


Episode 2177 - On this Saturday's show, Vinnie Tortorich welcomes Jen Mendyka whose story is a success-in-progress, and they chat about her current weight loss, health improvements, the food pyramid, and more. https://vinnietortorich.com/2022/08/success-progress-episode-2177 PLEASE SUPPORT OUR SPONSORS SUCCESS-IN-PROGRESS Vinnie welcomes Jen to the show and lets her know what a great inspiration she's been to him and others. (1:30) Vinnie asks Jen for her backstory on how she discovered NSNG®. (1:50) Jen discovered Vinnie in a roundabout way and it took her a while to actually start. She was interested in helping her T2D husband. They chat about what some of her mindset had been growing up and what motivated her to finally really dial things in. (6:20) She has lost 50 lbs in 3 months! Jen is a success-in-progress and shared her "before/during" on Twitter. They also chat about the effects of certain foods like seed oils. (17:00) Vinnie tells a little story about a visit to Red Lobster. They then discuss the unfortunate mess that is called the Food Pyramid and the negative effects it's had on society. (21:15) Vinnie wants Jen to keep checking in with her progress! [the_ad id="20253"] PURCHASE BEYOND IMPOSSIBLE The documentary launched on January 11! Order it TODAY! This is Vinnie's third documentary in just over three years. Get it now on Apple TV (iTunes) and/or Amazon Video! Link to the film on Apple TV (iTunes):  Then, Share this link with friends, too! It's also now available on Amazon (the USA only for now)!    Visit my new Documentaries HQ to find my films everywhere: REVIEWS: Please submit your REVIEW after you watch my films. Your positive REVIEW does matter! FAT: A DOCUMENTARY 2 (2021) Visit my new Documentaries HQ to find my films everywhere: Then, please share my fact-based, health-focused documentary series with your friends and family. The more views, the better it ranks, so please watch it again with a new friend! REVIEWS: Please submit your REVIEW after you watch my films. Your positive REVIEW does matter! FAT: A DOCUMENTARY (2019) Visit my new Documentaries HQ to find my films everywhere: Then, please share my fact-based, health-focused documentary series with your friends and family. The more views, the better it ranks, so please watch it again with a new friend! REVIEWS: Please submit your REVIEW after you watch my films. Your positive REVIEW does matter!  

Diabetes Connections with Stacey Simms Type 1 Diabetes
In the News... Misdiagnosed with type 2, Omnipod 5 approved for toddlers, Endocrinologist shortage and more!

Diabetes Connections with Stacey Simms Type 1 Diabetes

Play Episode Listen Later Aug 26, 2022 6:38


It's in the news! The top stories and headlines around the diabetes community this week include a new attempt to have fewer misdiagnoses of type 2 (when it's really type 1) diabetes, a new approval for Omnipod 5 down to two years old, a look at the endocrinologist shortage in the US, a milestone for Tandem and more! Check out Stacey's book: The World's Worst Diabetes Mom! Join the Diabetes Connections Facebook Group! Sign up for our newsletter here ----- Use this link to get one free download and one free month of Audible, available to Diabetes Connections listeners! ----- Episode Transcription Below (or coming soon!) Please visit our Sponsors & Partners - they help make the show possible! *Click here to learn more about OMNIPOD* *Click here to learn more about AFREZZA* *Click here to learn more about DEXCOM* Hello and welcome to Diabetes Connections In the News! I'm Stacey Simms and these are the top diabetes stories and headlines of the past seven days. XX In the news is brought to you by T1D Exchange! T1D Exchange is a nonprofit organization dedicated to improving outcomes for the entire T1D population. https://t1dexchange.org/stacey/ XX New effort to avoid the very common misdiagnosis of type 2 when it's actually type 1. JDRF and a a company called IQVIA are seeing if artificial intelligence can be used here. IQVIA used machine learning to look at data from individuals diagnosed with T2D and then, later, diagnosed with T1D within a specific time frame. The big problem, the company says, is that medical records are often incomplete and are compiled using different standards and formats. They call it a good starting point though. Earlier studies have shown that possibly 40-percent of adults with new onset type 1 are first misdiagnosed with type 2. https://www.jdrf.org/blog/2022/08/11/iqvia-algorithm-for-misdiagnoses/ XX New UK study about COVID, diabetes and kids.. shows there was an increase in new cases and in DKA. This was from March 2020 to February of 2021, compared to same time the previous year. This was a large study, looking back at cases across 49 sites. There was a 17% increase in new-onset diabetes from Year 1 to Year 2, mostly of type 1 diabetes. ED visits for DKA dropped by 31.9% during the pandemic year among patients with existing diabetes. There was a 43% increase in severity of new-onset disease from Year 1 to Year 2, with severe DKA increasing by 79% (P < .001) and intensive care admissions by 89% (P < .05 There were limitations to this study, the biggest is that data was only captured for those who went to the emergency room. The question of whether SARS-CoV-2 can trigger new-onset diabetes remains unanswered. https://www.medscape.com/viewarticle/979381#:~:text=There%20was%20a%2017%25%20increase,by%2079%25%20(P%20%3C%20. XX Omipod 5 is now FDA approved for kids as young as two. Omnipod 5, the first tubeless automated insulin delivery (AID) system in the U.S., was originally cleared for use in individuals aged six and older in January 2022. That makes Omnipod 5 the only AID approved for the toddler set. Tandem's Control IQ ia approved down to age 6 and Medtronic 780G down to age 7 https://www.businesswire.com/news/home/20220822005158/en/Insulet-Announces-FDA-Clearance-of-Omnipod%C2%AE-5-for-Children-Aged-Two-Years-and-Older-with-Type-1-Diabetes XX Milestone from Tandem they say that in the first month since the new mobile bolus feature was released, users have delivered more than 1 million insulin boluses. The company said in a news release that it is the first-ever FDA-cleared smartphone application capable of initiating insulin delivery on both iOS and Android operating systems. The company added that it is now available on approximately 30 different devices. https://www.drugdeliverybusiness.com/tandem-diabetes-app-insulin-bolus-million/ XX What looks like an editorial in a publication called Stability Health caught my eye. It's all about the shortage of endocrinologists in the US. Right now there are only 8-thousand in practice across the whole country. Endocrinologists receive the lowest compensation of all internal medicine (IM) specialties — lower even than practicing general internists — and 76–89% of medical students graduate with astronomical debt. Additionally, these clinicians often make themselves available outside of their office hours. But since this time may not be billable, it is often not supported in salaried compensation. Separately (but related), in 2016, 71% of entrants to the field of endocrinology were female. Due to America's long-standing gender wage gap, this may be a contributing factor in wage stagnation. Roughly 85% of Americans with diabetes rely on a general practitioner for their care. I'll link up the column so you can take a look. https://stabilityhealth.com/endocrinologist-shortage/?fbclid=IwAR0jx-nSiOL2UccmoJ9H74SnC6l3M5CCppecGcQ2t2M_zc7U-ydOj4JxfQ4#:~:text=Today%2C%2034.2%20million%20Americans%20are,currently%20practice%20in%20the%20U.S XX Update on one of the CGM smartwatches we've been keeping an eye on.. the K-Watch Glucose CGM watch is being tested by a French Company. They had their first clinical trials last year and got results this summer. the first run had a MARD of 29-percent.. brought down to a much better 16-percent. MARD is of course Mean Absolute Relative Difference to a calibrated meter and the gold standard right now is under 10 with Dexcom and Libre's next offerings closer to 8.. so a way to go here. https://www.notebookcheck.net/Painless-K-Watch-Glucose-blood-free-CGM-smartwatch-produces-positive-first-in-human-trial-results-as-PKvitality-targets-2024-for-availability.642380.0.html XX Back to the news in a moment but first.. The T1D Exchange Registry is a research study conducted online over time, designed to foster innovation and improve the lives of people with T1D. The platform is open to both adults and children with T1D living in the U.S. Personal information remains confidential and participation is fully voluntary. Once enrolled, participants will complete annual surveys and have the opportunity to sign up for other studies on specific topics related to T1D. The registry aims to improve knowledge of T1D, accelerate the discovery and development of new treatments and technologies, and generate evidence to support policy or insurance changes that help the T1D community. By sharing opinions, experiences and data, patients can help advance meaningful T1D treatment, care and policy. The registry is now available on the T1D Exchange website and is simple to navigate, mobile and user-friendly. For more information or to register, go to www.t1dregistry.org/stacey XX Association of Diabetes Care and Education Specialists gave their lifetime Achievement Award to Dr. Kenneth Moritsugu, former surgeon general of the United States. Many of you may know him as the Chairman of the Board of Children with Diabetes you see him at Friends for Life and other events. He's been involved with lot of national diabetes groups and effort – he was diagnosed with LADA at age 55. He's also been a guest of this show.. so congrats Dr. Moritsugu. https://www.healio.com/news/endocrinology/20220814/a-lifetime-of-service-a-conversation-with-kenneth-moritsugu-md-mph-facpm-faade?fbclid=IwAR2DyFSAyxCqeGMpmGHAi1FG1swihxFAPe-WveCaCP6NJrcUd0rFioBedQU XX Next week we're talking back to school! The wonderful diabetes educator Anna Sabino from Finding Smiles coaching will join me to talk 504, remote monitoring, supplies and lots more. The long format episode out right now is with Patients For Affordable Drugs about the bill that passed the Senate this week. The insulin copay cap was removed, but what does it really mean for medication prices? Listen wherever you get your podcasts That's In the News for this week.. if you like it, please share it! Thanks for joining me! See you back here soon.

Functional Medicine Research with Dr. Nikolas Hedberg
Berberine: Benefits and Clinical Applications

Functional Medicine Research with Dr. Nikolas Hedberg

Play Episode Listen Later Aug 25, 2022 20:53


Berberine is an isoquinolone alkaloid that is bitter and bright golden yellow in color. It is derived mainly from the roots, stems and rhizomes of plants such as Coptis chinensis (Chinese golden thread), Hydrastis canadensis (goldenseal), Berberis aquifolium (Oregon grape), and Berberis vulgaris (barberry). It has been used for thousands of years in traditional Chinese and Ayurvedic medicine and is generally considered safe, though it should be avoided during pregnancy and lactation. Berberine Click here to learn more about the Hedberg Institute Membership. Gastrointestinal side effects may occur due to berberine's impact on bowel motility. These include abdominal pain, distention, nausea, vomiting, and constipation. Side effects appear to be dose dependent, with increased symptoms such as low blood pressure, dyspnea, and flu-like symptoms at higher doses. Berberine is commonly used as an antibacterial, antiviral, antimicrobial, antifungal, and antihyperlipidemic agent. The many therapeutic applications of berberine are due to its antioxidant and anti-inflammatory properties, making it one of the top supplements of choice in clinical practice. It has traditionally been used for gastrointestinal related issues as well as issues involving liver dysfunction, digestive complaints, blood sugar regulation, inflammation, and infectious diseases. While berberine has exhibited a bioavailability of

Endocrine News Podcast
ENP56: Gestational Diabetes, Maternity Blues, and T2D

Endocrine News Podcast

Play Episode Listen Later Aug 24, 2022 11:20


In this episode, Aaron talks with Jennifer Dias from the Icahn School of Medicine at Mount Sinai about gestational diabetes, its association with postpartum depressive symptoms ("maternity blues"), and a predictor that may help prevent gestational diabetes from developing into type 2 diabetes. Ms. Dias, an MD candidate, presented research at ENDO 2022 titled, "Predictors of Postpartum Depressive Symptoms in Women with Recent GDM." For more information, including helpful links and other episodes, visit our website at https://www.endocrine.org/podcast

The NACE Clinical Highlights Show
Sponsored Content - The 411 on a GLP-1; Episode 3 - What T2D Therapy Have You Considered for Your Patients After Metformin?

The NACE Clinical Highlights Show

Play Episode Listen Later Aug 23, 2022 41:32


Podcast Series Title: The 411 on a GLP-1Podcast Series Description: Join series host Dr. Jim Gavin, Clinical Professor of Medicine at Emory University and Chief Medical Officer for Healing our Village in Atlanta, Georgia, and fellow leaders in the field of diabetes as they tackle some of the challenges we face when treating T2D. Topics of discussion include clinical inertia, as well as the mechanism of action, dosing, efficacy, and safety of a GLP-1 RA for adults with T2D. Episode Title: What T2D Therapy Have You Considered for Your Patients After Metformin?Episode Description: How common is treatment inertia in the treatment of adult patients with T2D and what can be done about it? Join a multidisciplinary panel including Jim Gavin, MD, PhD; Steve Vacalis, DO; and Jodi Strong, DNP, CDE, BC-ADM, CPT as they discuss and share their insights on the issues surrounding therapeutic inertia. They will also evaluate when to use a GLP-1 RA, and a clinical trial comparing the efficacy and safety of a GLP-1 RA versus a DPP-4i.This program is intended for clinicians. The information presented is aligned with the views and opinions of the speakers and is sponsored by Novo Nordisk. This podcast is not to be used as medical advice and is intended for educational purposes only.Faculty Presenters:James R. Gavin III, MD, PhDClinical Professor of Medicine, Emory UniversityChief Medical Officer, Healing Our Village, Inc.Atlanta, GeorgiaJodi Strong, DNP, CDCES, BC-ADM, CPTAspirus Medical GroupStevens Point, WisconsinSteve Vacalis, DOSenior Lead PhysicianCaroMont Family Medicine, CaroMont Regional Medical Center Gastonia, North Carolina 

The Fasting Highway
Episode 136 Jenni Warren-Zielke An inspiring intermittent fasting story, over coming sensitivities and food addiction.

The Fasting Highway

Play Episode Listen Later Aug 14, 2022 59:51


Jenni Zielke, 61, lives in Green Valley, Arizona, in the United States, about 30 miles from the Mexican border with her husband Larry. Jenni and her husband are originally from Wisconsin and only moved to Arizona in 2019, where they are partially retired. Jenni's career in Human Resources for manufacturing plants has meant working intimately with other people and their careers. This has been both a blessing and a curse, as Jenni navigated her own journey as a Highly Sensitive Person in a leadership role. Being partially retired, Jenni had more time on her hands, when she could eat more and become unhealthier, or find a new life. The new life she found is IF. Jenni was diagnosed 10 years ago with: T2D, Non-Alcoholic-Fatty-Liver, high BP, and diverticulosis. She also had intense joint pain in her feet, knees, hips, and neck. Jenni has been overweight since puberty. She remembers at 12 years old, seeing the boys wrestling team's weights posted in the hallway at school. This was the first time she realized her weight was way higher than the highest weighted boys older than her. Since then, Jenni continually gained weight up to her highest of 247 lbs/112 kgs. As a child, Jenni was often reminded she was overly sensitive, which she grew up believing was a character flaw. It is only through IF, that Jenni was able to fully appreciate her people-pleasing sensitivities were literally feeding her food addiction. Most importantly, The Fasting Highway has provided Jenni the tools to appreciate the blessings of being a highly sensitive person. With the help of TFH, Jenni is finally able to be sensitive to her own emotional needs. Jenni refers to herself as a recovering people-pleaser and works daily to keep her emotions separate from her food relationship. Jenni has found a supportive home in TFH group, along with new daily practices to support her new life as an IF'er. 61 years old 5'6” HW 247 lbs/112 kgs SW 225 lbs/102 kgs CW 181 lbs/82 kgs GR maybe 170-175 lbs/77-79 kgs The Fasting Highway News. My book about my own story The Fasting Highway is available on Amazon in both paperback and kindle. The Fasting Highway: Graeme Currie takes you on a journey through the highs and lows of beating a crippling food addiction by losing 60kg (132 pounds) living an Intermittent Fasting Lifestyle. For Australian and New Zealand residents, you can buy the book direct from me at www.thefastinghighway.com. For the rest of the world Amazon is your best option. You can follow me on Instagram at graemecurrie_63 or join The Fasting Highway Facebook Community. Enjoy The Show Graeme. Disclaimer all views expressed in this podcast episode are those of the guest and host. No part of this podcast should be taken as medical advice. Please consult your medical professional before starting any health plan. --- Send in a voice message: https://anchor.fm/graeme-currie/message

Surfing the Nash Tsunami
S3-E40.2 - A Simple Diagnostic Algorithm for Lean NASH

Surfing the Nash Tsunami

Play Episode Listen Later Aug 13, 2022 13:04


As the NASH pandemic grows in the number and diversity of patient cases, one patient group receiving increased notice includes patients with "lean NASH," those with "normal" BMI levels (BMI

Boundless Body Radio
Reversing Diabetes with Award-Winning Filmmaker Charles Mattocks! 320

Boundless Body Radio

Play Episode Play 24 sec Highlight Listen Later Aug 12, 2022 63:53


Charles Mattocks is an author, actor, producer, director, and health advocate. His work has been showcased with appearances on CNN, The Today Show, Dr. Oz, Fox News, Good Morning America, The Talk, The Martha Stewart Show and numerous media outlets worldwide. A desire to create meals that were tasty, nutritious, and affordable also led to his career as "The Poor Chef”, which gave him the opportunity to share what he had learned about feeding a family for less money. After a personal health crisis struck him, he changed his focus to be a voice and a force for serious change in the health industry. The Diabetic You documentary, website, and movement came out of that determination to educate and inspire people around the world, and the world is learning about Charles' war against diabetes. He is the creator of the reality TV series Reversed, a documentary about stopping the destruction of uncontrolled diabetes. Reversed takes us into the lives of several people living with diabetes and tells some of their stories of healing and progress!Find Charles at-https://www.bellaandellemedia.com/https://www.charlesmattocks.com/TW- @cmattocks1IG- @charlesmattocks1Special love to-Keto Chow!Find Boundless Body at-myboundlessbody.comBook a session with us here! 

Surfing the Nash Tsunami
S3-E40 - Best Practices in Lean NASH -- Authors Provide Back Story

Surfing the Nash Tsunami

Play Episode Listen Later Aug 11, 2022 52:56


As the NASH pandemic grows in the number and diversity of patient cases, one patient group receiving increased notice includes patients with "lean NASH," those whose BMI levels are "normal." Last month, Gastroenterology published Best Practice recommendations for diagnosing and treating lean NASH. Two of the authors, Drs. Michelle Long and Mazen Noureddin, were good enough to come on the podcast to share the thinking behind this article along with its key observations and recommendations.This conversation starts with Roger Green asking Michelle and Mazen how they came to write this piece and how the paper came together working with co-author, Dr. Joseph Lim. First, as Michelle notes, "we had to all get on the same page," on the issue of the highest BMI that would be considered lean or, more precisely, not overweight. From there, the team outlined 15 Best Practices based on clinical experience, and set out to refine these based on relevant literature and recommendations from colleagues and reviewers. The co-authors note that while little of what they learned while preparing this paper was surprising, it forced them to focus on creating a fairly simple set of stepwise goals for clinicians to follow.  Louise Campbell joins the conversation to praise the simplicity and clarity of the Best Practices chart the co-authors created. After noting that this algorithm is not very different from others,  Mazen goes on to mention "a couple of things...that we're proud of:" identification of high-risk patients based on age (over 40) or presence of Type 2 diabetes. He also notes that they provided greater clarity around more advanced non-invasive tests like ELF, MAST, FAST, MEFIB, MRI, and cT1.The conversation shifts to focus on the recommendation to retest every 6 or 12 months. Louise notes this approvingly. The group agrees that screening T2D patients annually using FIB-4 is not very different than screening annually for eye, kidney or neurological complications. Roger Green joins the conversation to suggest a 3-5 year follow-up recommendation is not patient-centric, but might calm payers concerned about skyrocketing costs of treating Fatty Liver disease. Mazen shares his expectation that yearly evaluation will be cost-effective and patient-centric. Roger shares an informal belief he has developed that whether due to later stage diagnoses or different disease pathogenesis, lean NASH patients might be more costly because patients progress to cirrhosis more quickly after the original diagnosis. Michelle tends to agree but notes that more research is needed on this.Next, the conversation shifts toward diagnostic approaches. Roger mentions the possible benefit of the "Fibrosis First" method that Ian Rowe discussed the previous week (S3, E39), particularly appropriate when primary care providers observe danger signs in lean patients. Mazen points to extremely elevated liver enzyme levels (ALT of 80 or 90). Michelle agrees, but notes that most of her lean NASH patients are diagnosed in an ED with complications of cirrhosis. The group then spends time asking what might make primary care providers comfortable testing for fibrosis, even if only to pass the patient on to the appropriate specialist.  Roger asks what different groups can learn from this paper. Michelle states that this is a clear call for more research. Mazen points to Table 2 in the paper, which lists other diseases that hepatologists should consider when evaluating these patients. He continues to state that the document is helpful for non-hepatologists and hepatologists alike. Finally, he points out that clinical trials are pivotal for these patients. The last several moments focus on how to ask patients about alcohol consumption and then the closing question. Michelle notes the importance of using lists and tables in the paper to guide the special issues in treating these patients. 

Boundless Body Radio
The BioDiet with Dr. David Harper! 319

Boundless Body Radio

Play Episode Play 25 sec Highlight Listen Later Aug 10, 2022 71:27


Dr. David G. Harper is a health educator and cancer researcher, and has studied the impact of diet on human health for many years. The culmination of that extensive work is the BioDiet , a ketogenic food regimen that he created in 2012. The significant weight loss and health improvements he experienced led Dr. Harper to counsel thousands of people on the BioDiet, in clinical trials and on a personal basis, with consistent, impressive results. He is the author of the bestselling book BioDiet: The Scientifically Proven, Ketogenic Way to Lose Weight and Improve Health, which has become an international best-seller, reaching as high as #18 globally for books overall on Amazon.com. Dr. Harper is an Associate Professor of Kinesiology at the University of the Fraser Valley and a Visiting Scientist at the BC Cancer Research Center, Terry Fox Laboratory. He holds a Ph.D. from the University of British Columbia and completed a post-doctoral fellowship in comparative physiology at the University of Cambridge. He is on the Scientific Advisory Board of the Canadian Clinicians for Therapeutic Nutrition and a member of the Institute for Personalized Therapeutic Nutrition. His present research investigates the therapeutic benefits of ketogenic diets for women with metastatic breast cancer. He is a great friend and a great human being!Find Dr. Harper at-https://www.biodiet.org/LK- Dr. David G. HarperFB- @Dave HarperCheck out his amazing talk at Keto Salt Lake 2022!Find Boundless Body at-myboundlessbody.comBook a session with us here! 

Taking Control Of Your Diabetes - The Podcast!
#9 - ADA Standards of Care with Dr. Robert Gabbay (ADA Chief Scientific & Medical Officer)

Taking Control Of Your Diabetes - The Podcast!

Play Episode Listen Later Aug 7, 2022 33:14


TAKING CONTROL OF YOUR DIABETES – THE PODCAST! ...With Expert Endocrinologists Living with T1D, Drs. Steven V. Edelman & Jeremy PettusADA Standards of Care – Dr. Robert Gabbay (ADA Chief Scientific & Medical Officer)Questions We'll Cover in This Episode:•  What are the ADA Standards of Care?•  What have been the newest changes to the treatment algorithm type 2 diabetes? What new data from clinical trials lead to these changes?•  What are the current guidelines for starting insulin and how have they changed for T2D?•  What do these guidelines provide in terms of access?•  What do these guidelines suggest for weight loss as a goal?•  What is the first question your provider should ask when evaluating you?•  What are the guidelines around pregnancy for women with type 1?•  What factors go into deciding the right insulin regimen for someone with T1D?ADA Standards of Care Resources: https://professional.diabetes.org/content-page/practice-guidelines-resources**Tune in for 2 new episodes each month! Like what you hear and want to help us grow? Please rate and review this podcast so we can reach more people living with diabetes!** ★ Support this podcast ★

Deconstructing Dallas
Tom Foley: T2D and Culinary Advocacy

Deconstructing Dallas

Play Episode Listen Later Jul 29, 2022 30:01


In the 2nd part of this joint episode, Ryan and Shawn talk with Tom Foley, Founder of T2D Concepts.After actively practicing law for 15+ years, Tom directed his efforts to designing innovative, social entrepreneurially models to drive social justice. In 2016, Tom partnered with celebrity chef Tiffany Derry to launch Roots Chicken Shak. The Shak, along with the Shef Tiffany spice line and the Roots Southern Table, combines culinary skills with social impact, empowering women and girls to follow their passion. https://www.t2dconcepts.com/

Taking Control Of Your Diabetes - The Podcast!
#8 - Top Tips from Endos for T2Ds

Taking Control Of Your Diabetes - The Podcast!

Play Episode Listen Later Jul 25, 2022 31:45


TAKING CONTROL OF YOUR DIABETES – THE PODCAST! ...With Expert Endocrinologists Living with T1D, Drs. Steven V. Edelman & Jeremy PettusTop Tips from Endos for T2Ds – Featuring Tricia Santos, MD, and Schafer Boeder, MDQuestions We'll Cover in This Episode:•  What are things we're always telling our patients with T2D? •  What are our recommendations for weight management? •  What are our recommendations for medications?•  What are our recommendations for technology/devices? •  What are our tips for avoiding diabetes burnout? Medications Mentioned...GLP1 Receptor Agonists: Trulicity, OzempicSGLT2 Inhibitors: Jardiance FarxigaFree Dexcom CGM Trial: https://www.dexcom.com/en-CA/hello-dexcom-join-trialFree Abbott FreeStyle Libre CGM Trial: https://www.freestyle.abbott/us-en/myfreestyle.htmlTCOYD Type 2 Facebook Group: https://www.facebook.com/groups/380141556250464Dr. Bill Polonsky and Behavioral Diabetes Institute: https://behavioraldiabetes.org/**Tune in for 2 new episodes each month! Like what you hear and want to help us grow? Please rate and review this podcast so we can reach more people living with diabetes!**★ Support this podcast ★

The Beating Diabetes Lifestyle Podcast With Oscar Camejo
TBDP11 - "Sugar Daddy: How to Stop Sugar Cravings" (Re-Air)

The Beating Diabetes Lifestyle Podcast With Oscar Camejo

Play Episode Listen Later Jul 6, 2022 32:45


Sugar. What's the big deal? Many of us consume too much sugar over a long period of time, and eventually develop certain health conditions that alter our lives. There's a problem. According to the Center for Disease Control (CDC), “Americans are eating and drinking too many added sugars, which can contribute to health problems such as weight gain and obesity, type 2 diabetes, and heart disease. To live healthier, longer lives, most Americans need to move more and eat better, including consuming fewer added sugars.”  (https://www.cdc.gov/nutrition/data-statistics/added-sugars.html)In this re-aired episode of “The Beating Diabetes Podcast,” I share my personal story and experience with sugar cravings and addiction, and exactly what I did to kick the habit. I use to be 268 pounds, overweight, sluggish, and unexplainably moody. One day, I found myself hospitalized and learned that I had developed Type 2 Diabetes (T2D).As of this episode, I lost over 80 pounds, I'm off insulin, and have reversed (T2D). Losing those 80+ pounds wasn't easy, but it was worth the effort. I'm healthy, alive, and on a mission to help diabetics who are overweight, have unhealthy nutritional habits, and are in need guidance for transforming their lives in order to reverse Type2 diabetes. I believe you can transform your life, be healthy, and feel alive! The way how is not complicated._____________________Resources Mentioned:“Glucose Revolution: The Life-Changing Power of Balancing Your Blood Sugar” by Jessie Inchauspé (https://www.glucose-revolution.com)“The Blood Sugar Solution 10-Day Detox Diet: Activate Your Body's Natural Ability to Burn Fat and Lose Weight Fast” by Dr. Mark Hyman, M.D. (https://drhyman.com)_____________________Connect With MeTo submit a question or join my mailing list, use the information below to connect with me.Web - beatingdiabeteslifestyle.com Email - hello@beatingdiabeteslifestyle.comInstagram - @beatingdiabeteslifestyle Facebook - https://www.facebook.com/groups/beatingdiabeteslifestyle HiHo - https://hiho.link/g/beatingdiabeteslife_____________________©2022 Oscar Camejo - The Beating Diabetes Lifestyle

The Fasting Method Podcast
Fasting Q&A: Blood Ketones, Weight-Loss Protocol, Not Losing Weight, and Mood Issues

The Fasting Method Podcast

Play Episode Listen Later Jul 5, 2022 37:41 Very Popular


Episode #34 In this Fasting Q&A episode, Megan and Nadia answer your fasting questions: 1. I'd like to fast primarily for therapeutic reasons (mental health and autophagy especially) and aim to do three 42s. My issue is raging ketones! How high is too high when it comes to BK and at what point should I break a fast for this reason? [01:18] 2. What is the best protocol for weight loss? [11:58] 3. I am a TOFI and a pre-diabetic. What fasting can I do to reverse my T2D without losing weight? I noticed when I do extended fasting of 42 hours I lose too much weight. [21:18]  4. The one issue that I'm having the hardest time with is my mood during an extended fast (longer than 24 hours). I feel extremely irritable, agitated, quick tempered, & anxious, which is not how I normally am. I don't know if it's my cortisol levels, or what. Is this common? [31:08]  Have questions you want us to answer? Please email them to: podcast@thefastingmethod.com Learn More About Our Community: https://www.thefastingmethod.com Join our FREE Facebook Group: https://bit.ly/TFMNetwork Watch Us On YouTube: https://bit.ly/TFMYouTube Follow Us on Instagram: @fastingmethod

Healthy Habits 4 Life with Dr. Carol Perlman
70 - Jan Gomes - The Inspiring Story of Reversing Type 2 Diabetes

Healthy Habits 4 Life with Dr. Carol Perlman

Play Episode Listen Later Jul 4, 2022 43:18


A severe health problem can disrupt all aspects of your life. But you can take steps to better cope with your new situation, and knowing that you are not powerless is vital! Join Carol as she speaks with Jan Gomes about her incredible story of reversing type 2 diabetes. Stay tuned! Here are the things to expect in the episode: How can you make dietary changes to manage diabetes? How do you stay motivated over time when it requires constant effort? Why should you get support from professionals? What is the best way to advocate for your needs in restaurants and with family members? And much more! About Jan: Jan was born and raised in NJ. She graduated from high school at the age of 17, turned 18 in October and joined the Army in December and never really looked back at NJ. Jan spent 3 years in the Army, mostly assigned to the Military Police School as a Company Clerk. In 1976 she got her Honorable Discharge, staying in Anniston AL for a few years. In 1980 she went to Germany with her now ex-husband for a year and then moved to Philadelphia, PA where she worked in the Investment Banking Industry. Jan divorced and met Abe, her current husband, online through a mutual friend. She left her life in Philly after 19 years and moved to Cumming GA to marry Abe. Jan worked briefly for ReMax but got bored and moved on to manage a Self Storage Facility and a Construction Office in Cumming. Cumming was starting to get crowded, so they bought our house in Dayton TN. During this period of time she gained weight and decided to join Weight Watchers. She ended up becoming a leader for 5 years until they shut down her area. Jan describes regaining the weight she had lost over the years in part due to stress eating. She was diagnosed with Type 2 Diabetes (Diabeasties is what she calls it), high blood pressure and high cholesterol (hereditary). She states that between her higher weight, Degenerative Disk Disease and Arthritis in her lower back, she could barely stand or walk. Jan was going through the pre-surgery motions with the VA to have gastric bypass surgery when things went downhill and she ended up in the hospital. There was one nurse who kept telling her she was going to die if she didn't get the T2D under control. Her final diagnosis was Acute Decompensated Heart Failure, a 'side' effect of T2D. Jan's mother died a week before her 70th birthday; her sister died 2 years before her 70th birthday. Both had T2D and did not adhere to a diabetic diet, eating donuts and candy and other junk all the time. When Jan was in the hospital with heart problems because of T2D and wasn't 65 yet, she realized she had to do something! That convinced her to change things immediately. The day she got out she weighed 256 pounds. She learned to change her diet. Jan is now hovering around that 150 pound mark and shares all the strategies she learned to use nutrition and exercise to reverse Type 2 Diabetes. It's a remarkable story! Carol and Jan met through a Facebook group for customers of Think Eat Live who love Sunflour products! Check out their website https://sunflour.io and enter promo code HEALTHYHABITS for a 20% discount on your order!Connect with Carol Perlman: Website: http://www.carolperlman.com/ | http://healthy4lifebycarolperlman.com Facebook: https://www.facebook.com/healthyforlifebycarolperlman/ LinkedIn: https://www.linkedin.com/in/carol-perlman-8a735513/ Email: carol@healthy4lifebycarolperlman.com

Physician's Weekly Podcast
Preventive Medicine: A Look At Diet For T2D And Colorectal Cancer Screening

Physician's Weekly Podcast

Play Episode Listen Later Jun 22, 2022 20:46


Welcome to this episode of Physician's Weekly podcast. I am your host, Dr. Rachel Giles, from Medicom Medical Publishers, in collaboration with Physician's Weekly. Today's theme is preventative medicine, with interviews about research in colorectal cancer screening and in dietary intervention in T2D patients to achieve remission. In case you haven't been exposed to it much, preventive medicine is a medical specialty that focuses on the health of individuals and communities. The goal of preventive medicine is to promote health and well-being and prevent disease, disability, and death. Preventive medicine specialists must have a broad range of medical skills as well as expertise in behavioral, economic, environmental, and social sciences. A doctor of preventive medicine can help create healthier communities, save lives, and transform healthcare systems.Later in this podcast, we speak with Dr. Richard Rosenfeld, about a recently published Expert Consensus Statement he authored with the aim to assist clinicians in achieving remission of type 2 diabetes (T2D) in adults using diet as a primary intervention. In that publication, expert consensus was achieved for 69 statements pertaining to diet and remission of T2D, dietary specifics and types of diets, adjuvant and alternative interventions, support, monitoring, adherence to therapy, weight loss, and payment and policy. Clinicians can use these statements to improve quality of care, inform policy and protocols, and identify areas of uncertainty. Prof. Rosenfeld is Chairman, and Program Director of Otolaryngology at SUNY Downstate University in New York.But first, we speak to Prof. Michael Kanter, from Kaiser Permanente's School of Medicine in California. He has had oversight of the quality of care provided by 22,000 physicians to 12.2 million patients within the healthcare system nationally and was responsible for the development of the organization's national quality strategy.  He works to significantly improve key clinical quality metrics, including cancer screenings, blood pressure control, and tobacco cessation. As you probably already know, Colonoscopy has played a pivotal role in the declining US incidence of colorectal cancer in persons older than 50 years observed over the past 2 decades. Physician's Weekly senior editor Martta Kelly speaks with Prof. Kanter about his ‘moonshot vision' of reducing mortality from colorectal cancer by 50% in 10 years, by improving quality metrics in colorectal cancer screening programs.  Enjoy listening!Further reading Kanter MH, et al. Beyond Screening: An Interim Report and Analysis of a Multimodal Initiative to Decrease Colon Cancer Mortality. Joint Commission Journal on Quality and Patient Safety, 2022, in press. https://www.jointcommissionjournal.com/article/S1553-7250(22)00086-1/fulltextRosenfeld RM, et al. Dietary Interventions to Treat Type 2 Diabetes in Adults with a Goal of Remission: An Expert Consensus Statement from the American College of Lifestyle Medicine. Am J Lifestyle Med. 2022 May 18;16(3):342-362. 

The NACE Clinical Highlights Show
CME/CE Podcast: GLP-1 RA - A Powerful Tool for Risk Reduction in Diabetes

The NACE Clinical Highlights Show

Play Episode Listen Later Jun 17, 2022 18:38


For more information regarding this CME/CE activity and to complete the CME/CE requirements and claim credit for this activity, visit: https://www.naceonline.com/courses/glp-1-ra-a-powerful-tool-for-risk-reduction-in-diabetesFeaturing speaker Javier Morales, MD, FACP, FACE, moderated by Gregg Sherman, MD.SummaryGlucagon-like peptide-1 receptor agonists (GLP-1 RAs) are a class of therapies used for the treatment of patients with type 2 diabetes (T2D). However, the role of GLP-1 RA therapy continues to evolve and expands beyond glycemic control for these patients, and includes cardiorenal protective effects. Recently updated clinical practice guidelines now recommend treatment with GLP-1 RA therapy that has demonstrated benefit in cardiovascular risk reduction in all patients with T2D.In this podcast episode, Dr. Javier Morales and Dr. Gregg Sherman discuss strategies for selecting optimal GLP-1 RA, the early initiation of GLP-1 RA therapy in appropriate patients, and improved adherence through adverse event management.This podcast was recorded and is being used with the permission of the presenters.Learning ObjectiveUpon completion of this activity, learners should be able to:Select GLP-1 RA therapy for early use in appropriate patients with T2DM, based on current guidelines, patient characteristics, and evolving data Incorporate management strategies for the adverse gastrointestinal effects of GLP-1 RAs to improve patient adherenceThis activity is accredited for CME/CE Credit.For more information regarding this CME/CE activity and to complete the CME/CE requirements and claim credit for this activity, visit: https://www.naceonline.com/courses/glp-1-ra-a-powerful-tool-for-risk-reduction-in-diabetesThe National Association for Continuing Education is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.The National Association for Continuing Education designates this enduring material for a maximum of 0.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.National Association for Continuing Education is accredited by the American Association of Nurse Practitioners as an approved provider of nurse practitioner continuing education. Provider number: 121222. This activity is approved for 0.25 contact hours (which includes 0 hours of pharmacology).This educational activity is supported by an independent educational grant from Novo Nordisk Inc.

Reshape Your Health with Dr. Morgan Nolte
126. How She Reversed Her Type 2 Diabetes with Terri Lance, PhD - Coach at The Fasting Method

Reshape Your Health with Dr. Morgan Nolte

Play Episode Listen Later Jun 8, 2022 55:27 Very Popular


In this episode, Terri Lance, PhD and coach for The Fasting Method, opens the show by revealing how she managed to reverse her type two diabetes diagnosis. Here's what we cover in this interview:How Dr. Terri Reversed Her Type Two Diabetes Through Lifestyle ChoicesWhy Do People Stay Stuck When It Comes To Their Health?How To Transform Your Fixed Mindset To A Growth MindsetHow To Allow Yourself To Let Go of Your Limiting Beliefs How To Be More Present For Your Own Internal Dialogue & Recommended Resources  Why Dr. Terri Is Currently Working on Navigating Imposter Syndrome AND MUCH MORE!Resources from this episode: https://www.zivli.com/blog/Terri-Lance-the-fasting-methodFollow Dr. Terri:LinkedIn: https://www.linkedin.com/in/terri-lan...Facebook: https://www.facebook.com/terrilancephd/Instagram: https://www.instagram.com/terri_lance...CoachingIf you're ready to lose the weight for good, you've come to the right place!Join my online course, Zivli, to learn the science behind weight loss and habit change so you can lose weight, get healthy, and prevent disease. To learn more, go to https://www.zivli.com/join. Free Weight Loss ResourcesWeight Loss Masterclass to Lower Insulin Resistance & InflammationConnect on Social>> Subscribe to My YouTube Channel>> Follow Me on Instagram>> View My Website

The 2TYPEONES Podcast
#91 Let's Meet Real Diabetic's - Susan Nash

The 2TYPEONES Podcast

Play Episode Listen Later May 28, 2022 86:57


In today's episode, we sit down with Susan Nash, a newly diagnosed type 2 diabetic. Susan isn't like your typical T2D. She shares her journey so far with diabetes and how she had to advocate for herself at diagnosis.Visit the Simplifying Diabetes Coaching WebsiteSimplifying Diabetes WebsiteSend me an email or DM me on Instagram and I'll answer any question you have about Diabetes.Don't forget to click on that subscribe button and leave a 5-star review on any platform you listen to the podcast, so you're notified when new episode drop. Questions about diabetes, don't hesitate to reach out @:Instagram: @the2typeonespodTwitter: @the2typeonespodTik Tok: @the2typonespodFacebook: @Simplifying Life With DiabetesEmail: the2typonespodcast@gmail.comPodcast Disclaimer: Nothing that you hear on The 2TYPEONES Podcast shouldn't be considered medical advice or otherwise; please always consult your medical TEAM before making any changes to your diabetes management.

PeerView Family Medicine & General Practice CME/CNE/CPE Video Podcast
Rajiv Agarwal, MD, MS - A Renewed Look at MRA Therapy: Improving Renal Outcomes and Reducing Risks in Patients With Type 2 Diabetes

PeerView Family Medicine & General Practice CME/CNE/CPE Video Podcast

Play Episode Listen Later May 26, 2022 36:01


Go online to PeerView.com/JNH860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. In this activity, an expert nephrologist examines the pathophysiology of chronic kidney disease (CKD) and the effects of mineralocorticoid receptor overactivation in patients with type 2 diabetes (T2D) to offer practical strategies for identifying which patients with CKD and T2D may benefit from treatment with nonsteroidal MRAs. Upon completion of this activity, participants should be better able to: Explain the pathophysiology of CKD progression and the effects of mineralocorticoid receptor overactivation in patients with T2D, Compare the mechanism of action, potency, selectivity, and physiological distribution of steroidal and nonsteroidal MRAs, Identify patients with CKD and T2D that may derive specific benefit from treatment with nonsteroidal MRAs.

PeerView Endocrinology & Diabetes CME/CNE/CPE Video Podcast
Rajiv Agarwal, MD, MS - A Renewed Look at MRA Therapy: Improving Renal Outcomes and Reducing Risks in Patients With Type 2 Diabetes

PeerView Endocrinology & Diabetes CME/CNE/CPE Video Podcast

Play Episode Listen Later May 26, 2022 36:01


Go online to PeerView.com/JNH860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. In this activity, an expert nephrologist examines the pathophysiology of chronic kidney disease (CKD) and the effects of mineralocorticoid receptor overactivation in patients with type 2 diabetes (T2D) to offer practical strategies for identifying which patients with CKD and T2D may benefit from treatment with nonsteroidal MRAs. Upon completion of this activity, participants should be better able to: Explain the pathophysiology of CKD progression and the effects of mineralocorticoid receptor overactivation in patients with T2D, Compare the mechanism of action, potency, selectivity, and physiological distribution of steroidal and nonsteroidal MRAs, Identify patients with CKD and T2D that may derive specific benefit from treatment with nonsteroidal MRAs.

PeerView Clinical Pharmacology CME/CNE/CPE Audio Podcast
Rajiv Agarwal, MD, MS - A Renewed Look at MRA Therapy: Improving Renal Outcomes and Reducing Risks in Patients With Type 2 Diabetes

PeerView Clinical Pharmacology CME/CNE/CPE Audio Podcast

Play Episode Listen Later May 26, 2022 36:02


Go online to PeerView.com/JNH860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. In this activity, an expert nephrologist examines the pathophysiology of chronic kidney disease (CKD) and the effects of mineralocorticoid receptor overactivation in patients with type 2 diabetes (T2D) to offer practical strategies for identifying which patients with CKD and T2D may benefit from treatment with nonsteroidal MRAs. Upon completion of this activity, participants should be better able to: Explain the pathophysiology of CKD progression and the effects of mineralocorticoid receptor overactivation in patients with T2D, Compare the mechanism of action, potency, selectivity, and physiological distribution of steroidal and nonsteroidal MRAs, Identify patients with CKD and T2D that may derive specific benefit from treatment with nonsteroidal MRAs.

The Beating Diabetes Lifestyle Podcast With Oscar Camejo
TBDP03 - "Sugar Daddy: How to Stop Sugar Cravings"

The Beating Diabetes Lifestyle Podcast With Oscar Camejo

Play Episode Play 30 sec Highlight Listen Later May 11, 2022 35:03


SHOW NOTESSugar. What's the big deal? Many of us consume too much sugar over a long period of time, and eventually develop certain health conditions that alter our lives. There's a problem. According to the Center for Disease Control (CDC), “Americans are eating and drinking too many added sugars, which can contribute to health problems such as weight gain and obesity, type 2 diabetes, and heart disease. To live healthier, longer lives, most Americans need to move more and eat better, including consuming fewer added sugars.”  (https://www.cdc.gov/nutrition/data-statistics/added-sugars.html)In this episode of “The Beating Diabetes Podcast,” I share my personal story and experience with sugar cravings and addiction, and exactly what I did to kick the habit. I use to be 268 pounds, overweight, sluggish, and unexplainably moody. One day, I found myself hospitalized and learned that I had developed Type 2 Diabetes (T2D).As of this episode, I'm 187 pounds, off insulin, and have reversed (T2D). Losing those 81 pounds wasn't easy, but it was worth the effort. I'm healthy, alive, and on a mission to help diabetics who are overweight, have unhealthy nutritional habits, and are in need guidance for transforming their lives in order to reverse Type2 diabetes. I believe you can transform your life, be healthy, and feel alive! The way how is not complicated._____________________Connect With Me:Email - hello@beatingdiabeteslifestyle.comInstagram - @beatingdiabeteslifestyle HiHo - https://hiho.link/g/beatingdiabeteslife_____________________Resources Mentioned:“Glucose Revolution: The Life-Changing Power of Balancing Your Blood Sugar” by Jessie Inchauspé (https://www.glucose-revolution.com)“The Blood Sugar Solution 10-Day Detox Diet: Activate Your Body's Natural Ability to Burn Fat and Lose Weight Fast” by Dr. Mark Hyman, M.D. (https://drhyman.com)

Endocrine News Podcast
ENP52R: Incretins and Type 2 Diabetes Management RE-RELEASE

Endocrine News Podcast

Play Episode Listen Later Apr 21, 2022 21:56


NOTE: This is an edited re-release of Episode 52. Hos